Idexx Laboratories (IDXX) Payables (2009 - 2026)

Idexx Laboratories' Payables history runs 18 years deep, the most recent figure standing at $130.0 million for Q1 2026.

• In Q1 2026, Payables rose 8.23% year-over-year to $130.0 million; the TTM figure through Mar 2026 stood at $130.0 million (up 8.23% YoY), while the FY2025 annual figure was $110.4 million, down 3.33% from the prior year.
• Payables for Q1 2026 stood at $130.0 million, up from $110.4 million in the prior quarter.
• The five-year high for Payables was $130.0 million in Q1 2026, with the low at $107.7 million in Q2 2023.
• The 5-year median for Payables is $116.6 million (2025), against an average of $116.2 million.
• The sharpest annual moves came in 2022 and 2023: Payables soared 38.66% in 2022, then decreased 15.4% in 2023.
• Idexx Laboratories' Payables stood at $110.2 million in 2022, then grew by 0.38% to $110.6 million in 2023, then increased by 3.22% to $114.2 million in 2024, then declined by 3.33% to $110.4 million in 2025, then gained by 17.72% to $130.0 million in 2026.
• Business Quant data shows IDXX's Payables at $130.0 million in Q1 2026, $110.4 million in Q4 2025, and $122.3 million in Q3 2025.